Current through October 23, 2024
Section 440 IAC 1.5-3-11 - Pharmacy servicesAuthority: IC 12-21-2-3; IC 12-25-1-2; IC 12-25-1-4
Affected: IC 12-25
Sec. 11.
The private mental health institution shall have a pharmacy service that ensures that medication use processes are organized and systematic throughout the facility. The following requirements apply:
(1) The facility shall do the following:(A) Identify an appropriate selection or formulary of medications available for prescribing or ordering.(B) Address the prescribing or ordering and the procurement of medications not available within the formulary.(2) Policies and procedures shall be in place to: (A) support safe prescription ordering and storage; and(B) address such issues as: (i) pain management medication; and (3) The facility shall adhere to law, regulation, licensure, and professional standards of practice regarding the preparation and dispensing of medication.(4) The preparation and dispensing of medication shall be appropriately controlled as follows: (A) The facility shall have an individual patient dose system in place.(B) A pharmacist shall review all medication prescriptions or orders, including a review for interactions and adverse effects.(C) A system shall be in place to assure that consumer medication information is considered when medication is prepared and dispensed for a consumer.(D) The facility shall have a procedure in place for the availability of pharmacy services at any time when the pharmacy is closed or otherwise unavailable.(E) Emergency medications shall be consistently available, controlled, and secure in the pharmacy and consumer care areas.(F) The facility shall have a medication recall system for the retrieval and safe disposal of:(iii) recalled; medications.(5) The facility shall have a system in place to ensure that:(A) prescriptions or orders are verified; and(B) consumers are properly identified; before any medication is administered or dispensed.(6) Any investigational medication shall be safely: (A) controlled and administered during any experimental or investigational trial; and(B) destroyed at the conclusion of any experimental or investigational trial.(7) A facility shall have the following in place:(A) A written policy that assures the routine inspection of the storage of all medications.(B) A written system to address appropriate storage and dispensing of sample medications. Division of Mental Health and Addiction; 440 IAC 1.5-3-11; filed Oct 11, 2002, 11:26 a.m.: 26 IR 744; filed Aug 11, 2008, 3:40 p.m.: 20080910-IR-440070875FRA; readopted filed Nov 5, 2008, 3:50 p.m.: 20081119-IR-440080742RFA; Readopted filed 8/11/2014, 11:21 a.m.: 20140910-IR-440140240RFAReadopted filed 11/9/2020, 3:09 p.m.: 20201209-IR-440200502RFA